Advanced epithelial ovarian cancer (EOC): Is there a place for maintenance therapy in patients with suboptimal debulking?

被引：0
|
作者：
Hariprasad, R. [1 ]
Kumar, L. [1 ]
Kumar, S. [1 ]
Bhatla, N. [1 ]
Thulkar, S. [1 ]
Das, P. [1 ]
机构：
[1] All India Inst Med Sci, New Delhi, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14580
引用
收藏
页数：2
相关论文
共 50 条
  • [21] NEOADJUVANT CHEMOTHERAPY AND INTERVAL DEBULKING FOR ADVANCED EPITHELIAL OVARIAN-CANCER
    JACOB, JH
    GERSHENSON, DM
    MORRIS, M
    COPELAND, LJ
    BURKE, TW
    WHARTON, JT
    GYNECOLOGIC ONCOLOGY, 1991, 42 (02) : 146 - 150
  • [22] Outcome of Interval Debulking in Advanced Ovarian Cancer Patients
    Suprasert, Prapaporn
    Tiyanon, Jittima
    Kietpeerakool, Chumnarn
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2008, 9 (03) : 519 - 523
  • [23] Ovarian cancer patients' knowledge of advanced ovarian cancer and maintenance therapy: Differences across disease and maintenance therapy status
    Meyer, Larissa
    Sun, Charlotte
    Lowenstein, Lisa
    Leal, Viola
    Crocker, Laura
    Basabe, M. Sol
    Schneider, Amy
    Iniesta-Donate, Maria
    Westin, Shannon
    Volk, Robert
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S234 - S234
  • [24] Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer
    Nasioudis, Dimitrios
    Byrne, Maureen
    Ko, Emily M.
    Haggerty, Ashley F.
    Cory, Lori
    Giuntoli, Robert L., II
    Kim, Sarah H.
    Latif, Nawar A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (12) : 1579 - 1583
  • [25] Quinary debulking for epithelial ovarian cancer
    Edwards, James M.
    Lowery, William Jeffrey
    Secord, Angeles Alvarez
    JOURNAL OF SURGICAL CASE REPORTS, 2012, (07):
  • [26] IMPACT OF INTRODUCING EXTENSIVE SURGICAL PROCEDURES TO CYTOREDUCTIVE SURGERY (CRS) IN ADVANCED EPITHELIAL OVARIAN CANCER (EOC) ON RATE OF COMPLETE DEBULKING (CD) AND SURVIVAL
    Seoud, M.
    El Housheimi, A.
    Jaafar, I.
    Hamed, K.
    Abdallah, R.
    Jamali, F.
    Khalil, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A147 - A148
  • [27] IMPACT OF INTRODUCING EXTENSIVE SURGICAL PROCEDURES TO CYTOREDUCTIVE SURGERY (CRS) IN ADVANCED EPITHELIAL OVARIAN CANCER (EOC) ON RATE OF COMPLETE DEBULKING (CD) AND SURVIVAL
    Seoud, M.
    El Housheimi, A.
    Jaafar, I.
    Hamed, K.
    Abdallah, R.
    Khalil, A.
    Jamali, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A43 - A44
  • [28] The role of factor (f) XIII in patients with advanced epithelial ovarian cancer (EOC) FIGO III/IV
    Yazdian, M.
    Ataseven, B.
    Schneider, S.
    Baert, T.
    Bommert, M.
    Traut, A.
    du Bois, A.
    Harter, P.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E212 - E212
  • [29] Interval debulking surgery for advanced epithelial ovarian cancer: A Cochrane systematic review
    Tangjitgamol, Siriwan
    Manusirivithaya, Sumonmal
    Laopaiboon, Malinee
    Lumbiganon, Pisake
    GYNECOLOGIC ONCOLOGY, 2009, 112 (01) : 257 - 264
  • [30] Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection
    Gill, Sarah E.
    McGree, Michaela E.
    Weaver, Amy L.
    Cliby, William A.
    Langstraat, Carrie L.
    GYNECOLOGIC ONCOLOGY, 2017, 144 (02) : 266 - 273
12345